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Proteomic identification of novel cytoskeletal 
proteins associated with TbPLK, an essential 
regulator of cell morphogenesis in Trypanosoma 
brucei
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Courtney J. Mercadantea, Sue Vaughane, and Christopher L. de Graffenrieda
aDepartment of Molecular Microbiology and Immunology, Brown University, Providence, RI 02912; bMax F. Perutz 
Laboratories, Department of Medical Biochemistry, Medical University of Vienna, 1030 Vienna, Austria; cMax F. Perutz 
Laboratories, Center for Molecular Biology, University of Vienna, 1030 Vienna, Austria; dMax F. Perutz Laboratories, 
Mass Spectrometry Facility, University of Vienna, 1030 Vienna, Austria; eDepartment of Biological and Medical 
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ABSTRACT Trypanosoma brucei is the causative agent of African sleeping sickness, a devas-
tating disease endemic to sub-Saharan Africa with few effective treatment options. The para-
site is highly polarized, including a single flagellum that is nucleated at the posterior of the 
cell and adhered along the cell surface. These features are essential and must be transmitted 
to the daughter cells during division. Recently we identified the T. brucei homologue of polo-
like kinase (TbPLK) as an essential morphogenic regulator. In the present work, we conduct 
proteomic screens to identify potential TbPLK binding partners and substrates to better un-
derstand the molecular mechanisms of kinase function. These screens identify a cohort of 
proteins, most of which are completely uncharacterized, which localize to key cytoskeletal 
organelles involved in establishing cell morphology, including the flagella connector, flagel-
lum attachment zone, and bilobe structure. Depletion of these proteins causes substantial 
changes in cell division, including mispositioning of the kinetoplast, loss of flagellar connec-
tion, and prevention of cytokinesis. The proteins identified in these screens provide the foun-
dation for establishing the molecular networks through which TbPLK directs cell morphogen-
esis in T. brucei.
INTRODUCTION
Trypanosoma brucei is the causative agent of human African 
trypanosomiasis in humans and nagana in cattle (Pays and 
Vanhollebeke, 2009; Brun et al., 2010; Mott et al., 2011; Welburn 
and Maudlin, 2012). These diseases cause tremendous harm in 
sub-Saharan Africa, in terms of both human health and economic 
stability (Fèvre et al., 2008). T. brucei is a unicellular eukaryote that 
is transmitted by the bite of the Glossina fly and cycles between 
two primary forms: the insect-resident procyclic form (PCF) and 
the mammalian-resident bloodstream form (BSF), which are both 
obligate extracellular pathogens that must disseminate effectively 
throughout their hosts to survive (Matthews and Gull, 1994; 
MacGregor et al., 2011; Aksoy et al., 2013).
Trypanosomes are highly polarized cells that are optimized to 
survive constant contact with the defenses of their hosts (Gull, 1999; 
Langousis and Hill, 2014). A series of subpellicular microtubules 
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Moreira-Leite et al., 2001; Briggs et al., 2004). The linked flagella 
are partitioned into separate flagellar pockets once they emerge 
onto the cell surface as part of the process of duplicating the bi-
lobe and FPC. This involves a dramatic rotation of the newly ma-
tured basal body that allows the new flagellum to extend without 
impinging on the old (Lacomble et al., 2010). The new FAZ is also 
initiated at this point and extends 1–2 μm behind the growing 
flagellum, adhering it to the cell body (Kohl et al., 1999). The new 
FAZ continues to extend as the kinetoplast and nucleus duplicate. 
The cytokinetic furrow initiates from the tip of the new FAZ, creat-
ing a precisely positioned furrow that partitions the duplicated or-
ganelles to produce two daughter cells (Ploubidou et al., 1999; 
Hammarton et al., 2003; Tu and Wang, 2004). This directly links the 
correct assembly and positioning of the new flagellum to the com-
pletion of cytokinesis. Perturbing flagellar positioning by deplet-
ing FAZ or bilobe components causes cytokinetic defects (He 
et al., 2005; Bonhivers et al., 2008; Vaughan et al., 2008; Ikeda and 
de Graffenried, 2012).
Despite a precise morphological understanding of how flagellar 
inheritance proceeds in trypanosomes, very little is known about the 
signaling pathways that coordinate these events during cell division. 
A NimA-related protein kinase homologue is essential for proper 
basal body duplication, whereas components of the chromosomal 
passenger complex (CPC) and the T. brucei Aurora kinase appear to 
leave the nucleus late in division to select a site for furrow ingression 
(Pradel et al., 2006; Li et al., 2008a, 2009). One candidate for a 
higher-level orchestrator of this process is T. brucei polo-like kinase 
(TbPLK), the single polo-like kinase homologue found in trypano-
somes (Kumar and Wang, 2006; Hammarton et al., 2007a; de 
Graffenried et al., 2008). During cell division, TbPLK first appears on 
the maturing basal body and then migrates to the bilobe/FPC as 
they duplicate (Ikeda and de Graffenried, 2012). The kinase subse-
quently localizes to the tip of the new FAZ and the FC as these 
structures position the new flagellum. Depletion or inhibition of 
TbPLK causes defects in basal body segregation and new FPC/bi-
lobe assembly and blocks the initiation and extension of the new 
FAZ (de Graffenried et al., 2008; Ikeda and de Graffenried, 2012; 
Lozano-Núñez et al., 2013).
Considering its importance in many different stages of flagellar 
inheritance, it is likely that understanding how TbPLK interacts with 
its substrates and binding partners would be an excellent approach 
to developing a mechanistic understanding of this process. However, 
many of the PLK substrates found in other organisms, such as Cdc25 
and Bub1, appear to be absent in trypanosomes (Yu et al., 2012). This 
is consistent with the fact that the kinase plays divergent roles in try-
panosomes compared with other organisms, in which polo homo-
logues are responsible for chromosome congression and other mi-
totic events (Archambault and Glover, 2009; Zitouni et al., 2014). 
These different roles are likely to be reflected by novel trypanosome-
specific substrates and interactors. Although we recently identified 
the calcium-binding protein TbCentrin2 as a viable TbPLK substrate, 
few other candidates are evident (de Graffenried et al., 2013).
In this work, we use phosphoproteomics and proximity-depen-
dent biotinylation (BioID) to identify potential TbPLK binding part-
ners and substrates. These approaches yield both new and previ-
ously identified components of the basal body, bilobe, FPC, and 
FAZ, which may play important roles in TbPLK signaling pathways. 
Among our candidates, we identify a FAZ protein that is essential for 
maintaining the kinetoplast on the posterior side of the nucleus 
similar to another recently described FAZ protein. We describe the 
first known component of the FC and show that this structure is not 
essential for flagellar positioning, as previously hypothesized. We 
underlies the cell surface, producing a cell with a long, tapered 
shape and distinct posterior and anterior ends (Figure 1; Sherwin 
and Gull, 1989; Robinson and Gull, 1991; Schneider et al., 1997). A 
single flagellum is nucleated at the posterior end of the cell from a 
basal body, which is linked to the mitochondrial DNA aggregate 
known as the kinetoplast (Vaughan, 2010; Langousis and Hill, 2014). 
Depending on the life cycle stage, the kinetoplast and basal body 
can be positioned to the posterior of the nucleus (trypomastigote) 
or toward the anterior (epimastigote; Hoare and Wallace, 1966). The 
flagellum transits through an invagination of the cell surface known 
as the flagellar pocket, which is the only compartment that is com-
petent for endocytosis and exocytosis (Gull, 2003; Field and 
Carrington, 2009). The flagellar pocket is tightly cinched at its top by 
the flagellar pocket collar (FPC), which encircles the flagellum 
(Bonhivers et al., 2008; Lacomble et al., 2009). A second cytoskele-
tal structure, known as the bilobe, is found to the dorsal side of the 
FPC and forms a hook around the flagellum (He et al., 2005; Esson 
et al., 2012).
The flagellum is adhered along the cell surface after exiting the 
flagellar pocket and extends for several micrometers past the ante-
rior end of the cell. Flagellar attachment is mediated by a structure 
known as the flagellum attachment zone (FAZ), comprising a series 
of junctions that span the plasma and flagellar membranes, forming 
a tight seal (Figure 1; Vickerman, 1969). The FAZ also includes a set 
of four microtubules, known as the microtubule quartet (MtQ), which 
nucleate at the basal body, wrap around the flagellar pocket, and 
assume a position next to the filament (Gull, 1999; Lacomble et al., 
2009). Cell polarity and flagellar attachment are essential for the 
motility of the parasite, which is necessary for transmission and for 
evasion of the host immune system (LaCount et al., 2002; Engstler 
et al., 2007). This positional information must be transmitted to the 
daughter cells along with the correct complement of organelles dur-
ing cell division to produce progeny that can survive within their 
hosts (McKean, 2003; Hammarton et al., 2007b; Farr and Gull, 
2012).
The process of flagellar positioning has been well described 
morphologically in T. brucei (Moreira-Leite et al., 2001; Gadelha 
et al., 2009; Lacomble et al., 2009, 2010). This process begins with 
the maturation of the probasal body, which docks with the flagellar 
pocket membrane and nucleates a new flagellum (Lacomble et al., 
2010; André et al., 2013). In PCFs, the new flagellum is physically 
linked to the old flagellum by a structure known as the flagella 
connector (FC), which is believed to direct the positioning of the 
new flagellum by using the old one as a template (Figure 1; 
FIGURE 1: Schematic of key cellular organelles involved in flagellum 
positioning. Model of a cell approximately halfway through cell 
division, where all the key cytoskeletal structures, such as the FC, are 
present or have already duplicated.
Nucleus, kinetoplast
Basal body
Flagellum
Flagellar pocket collar (FPC)
Bilobe
Flagellum attachment zone (FAZ)
Flagella connector (FC)
Subpellicular microtubules
Posterior Anterior
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the cytoskeleton, which are difficult to solu-
bilize under conditions that would preserve 
binding to TbPLK; moreover, the polo-box 
domain of TbPLK lacks key conserved resi-
dues involved in phosphospecific binding 
(Yu et al., 2012). To overcome these issues, 
we chose to use the recently established Bi-
oID method to identify proteins that neigh-
bor TbPLK. BioID uses a mutant of the bac-
terial biotin ligase BirA that generates highly 
reactive AMP-biotin and releases it into cy-
toplasm, where it rapidly reacts with free ly-
sine residues on nearby (within 10–12 nm) 
proteins (Roux et al., 2012). Fusing this BirA 
mutant, termed BirA*, to a protein of inter-
est leads to the biotinylation of the proteins 
in close proximity to the fusion. The biotinyl-
ated proteins can then be solubilized under 
denaturing conditions and captured using 
streptavidin beads.
BioID was recently used in T. brucei to 
identify a host of new bilobe components 
by fusing BirA* to the bilobe protein 
MORN1 (Morriswood et al., 2009, 2013). 
The plasmids and protocols established for 
MORN1 gave us a good starting point for 
performing BioID with TbPLK. We gener-
ated a myc-BirA*-TbPLK fusion in the doxy-
cycline-inducible vector pLEW100 and inte-
grated it into cells (29-13) that allow 
doxycycline-inducible expression (Wirtz 
et al., 1999). We were able to isolate clones 
that express detectable levels of BirA*-
TbPLK upon addition of as little as 10 ng/ml 
doxycycline. We chose to use 20 ng/ml dox-
ycycline for all our further work because this 
level of induction produced levels of BirA*-
TbPLK that were similar to those with the 
endogenous kinase, and cell growth was 
not affected by this level of expression 
(Figure 2A and Supplemental Figure S1). 
When lysates from induced and uninduced 
conditions were probed with horseradish 
peroxidase (HRP)–streptavidin, a clear in-
crease in biotinylated proteins could be 
seen upon addition of 50 μM biotin and the 
induction of the BirA*-TbPLK (Figure 2B). Induced and uninduced 
cells were fixed and labeled with Dylight 488–streptavidin to detect 
biotinylated proteins within the cell (Figure 2C). Specific signal along 
the basal body, bilobe, and FAZ was seen in cytoskeletal prepara-
tions from induced cells.
With these preliminary data, we decided to conduct large-scale 
streptavidin pulldowns on induced and uninduced samples. Ap-
proximately 2 × 109 cells were incubated with 20 ng/ml doxycycline 
or vehicle control for 18 h, followed by lysis in ionic detergent. Pull-
downs were then performed with streptavidin beads, followed by a 
series of stringent washes (Figure 2D). The bound proteins were 
eluted by on-bead tryptic digest, and the released peptides were 
identified by liquid chromatography–tandem mass spectrometry 
(LC-MS/MS). This protocol was repeated three times to assess the 
reproducibility of the streptavidin pulldown. Proteins that showed 
at least one unique peptide in each induced sample and had 
also identify a protein that localizes to the tip of the new FAZ that is 
necessary for both initiation of cytokinesis and recruiting TbPLK to 
the new FAZ. This list of potential TbPLK substrates and interactors 
will allow us to dissect TbPLK function at different cellular locations 
and establish mechanisms by which the kinase controls inheritance 
of the flagellum.
RESULTS
Identification of potential TbPLK binding partners 
using BioID
Previous work in other organisms identified PLK interactors using 
immunoprecipitation and by using the C-terminal phosphopeptide-
binding domain of the kinase, known as the polo-box, as an affinity 
reagent (Lowery et al., 2007; Snead et al., 2007; Bastos and Barr, 
2010). These methods are less likely to be successful in trypano-
somes because many interactors are expected to be components of 
FIGURE 2: Characterization of the Myc-BirA*-TbPLK cell line. (A) Cells carrying doxycycline-
inducible Myc-BirA*-TbPLK were treated with 20 ng/ml doxycycline (+) or a vehicle control (–), 
and then their lysates were probed with antibodies against TbPLK and Myc. Wild-type cells 
(control) were included as a control. (B) Myc-BirA*-TbPLK cells were treated (+) with 20 ng/ml 
doxycycline (DOX), biotin, or vehicle control (–), and then their lysates were probed with 
HRP-streptavidin to detect biotinylation. (C) Myc-BirA*-TbPLK cells were treated (+DOX) with 
doxycycline or a vehicle control (Control) and labeled with antibodies against the FAZ (FAZ; red) 
and either anti-Myc (Myc-BirA*-TbPLK; green) or Dylight 488–conjugated streptavidin 
(StrepAvidin; green), as well as with DAPI to label DNA (DNA; blue). (D) Myc-BirA*-TbPLK cells 
were incubated with biotin and either doxycycline (+) or a vehicle control (–), followed by lysis 
and incubation with streptavidin beads. The beads were washed, and 10% of the bound material 
was eluted and run on an SDS–PAGE gel, which was then imaged using SYPRO ruby.
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Gene ID Screen hit Location Notes
Tb927.1.1890 BioID WCL NUP
Tb927.10.14320 BioID WCL, P FAZ FAZ9; Sunter 
et al. (2015)
Tb927.11.11650 BioID WCL, P BB
Tb927.10.840 BioID WCL, P FAZ FAZ6; Sunter 
et al. (2015)
Tb927.11.15990 BioID WCL, P NUP
Tb927.9.7690 BioID WCL, S CYTO
Tb927.11.11080 BioID WCL NUP
Tb927.3.3130 BioID WCL CYTO
Tb927.11.3300 BioID WCL FAZ
Tb927.3.4960 BioID WCL, P CYTO
Tb927.10.3010 BioID WCL, P BILOBE Morriswood 
et al. (2013)
Tb927.10.15750 BioID WCL, P; 
SILAC; iTRAQ
BB p197; 
Gheiratmand 
et al. (2013)
Tb927.6.890 BioID WCL, P NUP
Tb927.11.980 BioID WCL, P NUP
Tb927.9.6460 BioID WCL NUP
Tb11.01.2730 BioID WCL, P BILOBE
Tb927.7.7400 BioID WCL, P BB
Tb927.10.12860 BioID WCL CYTO
Tb927.7.2640 BioID WCL, P, S CORSET
Tb927.11.15800 BioID WCL, P, S; 
SILAC; iTRAQ
FAZ TOEFAZ1; 
this work
Tb927.4.2000 BioID WCL, S CYTO
Tb927.11.6440 BioID WCL, S CYTO
Tb927.10.5810 BioID WCL, S CYTO
Tb927.7.3880 BioID WCL, S BB
Tb927.3.4400 BioID WCL, P BB
Tb927.7.6620 BioID WCL CYTO
Tb927.1.3200 BioID WCL CYTO
Tb927.5.2500 BioID WCL BILOBE
Tb927.9.8200 BioID WCL NUC
Tb927.7.2680 BioID WCL CYTO
Tb927.10.14890 BioID WCL CYTO
Tb927.10.8820 BioID WCL, P; 
SILAC; iTRAQ
BILOBE Morriswood 
et al. (2013)
Tb927.7.3330 BioID WCL, P FAZ Morriswood 
et al. (2013)
Gene ID Screen hit Location Notes
Tb927.10.1450 BioID WCL, P BILOBE Morriswood 
et al. (2013)
Tb927.10.850 BioID WCL, P BILOBE Morriswood 
et al. (2013)
Tb927.10.14520 BioID P BB
Tb927.4.2070 BioID P CYTO
Tb927.9.5750 BioID P CYTO
Tb927.11.10660 BioID P BB
Tb927.4.4180 BioID P BILOBE
Tb927.11.5640 BioID P; SILAC; 
iTRAQ
COLLAR
Tb927.11.8950 BioID P BILOBE LRRP1; Zhou 
et al. (2010)
Tb927.2.4230 BioID P NUP NUP-1; 
Dubois et al. 
(2012) 
Tb927.10.10360 BioID P CORSET MARP1; 
Schneider 
et al. (1988) 
Tb927.4.2080 BioID P FAZ CC2D; Zhou 
et al. (2011)
Tb927.9.13820 BioID P BB KMP-11; Li 
and Wang 
(2008)
Tb927.11.16050 BioID S CYTO
Tb927.9.10490 BioID S CYTO
Tb927.10.10890 BioID S CYTO
Tb927.4.2740 BioID S CYTO
Tb927.6.1520 BioID S SURFACE
Tb927.11.2610 BioID S CORSET
Tb927.5.1650 BioID S CYTO
Tb927.10.1450 BioID S BILOBE
Tb927.8.7070 SILAC; iTRAQ FAZ
Tb927.3.4250 SILAC; iTRAQ CYTO
Tb927.5.3460 SILAC; iTRAQ FAZ
Tb927.11.1340 SILAC CNTR FC1; this work
Tb927.10.5460 SILAC CYTO
Tb927.9.7520 SILAC CYTO
Tb927.10.2240 SILAC; iTRAQ CYTO
Tb927.10.7210 SILAC; iTRAQ FAZ
Tb927.1.4400 SILAC; iTRAQ BILOBE
The BioID hits are separated into proteins found in the whole-cell lysate (WCL), pellet (P), or supernatant (S) fractions. The phosphoproteomic hits are separated into 
SILAC or iTRAQ hits. The localization of each protein was established by tagging of the endogenous locus. BB, basal body; COLLAR, flagellar pocket collar; CNTR, 
flagella connector; CORSET, subpellicular microtubule corset; CYTO, cytoplasmic; NUC, nuclear; NUP, nuclear pore; SURFACE, cell surface.
TABLE 1: Proteins identified in the BioID and phosphoproteomic screens.
minimal or no peptides in the uninduced samples were considered 
to be specific hits and investigated further. This criterion produced 
35 candidate proteins (Table 1 and Supplemental Figure S2). Of 
interest, five of these proteins were present in the BirA*-MORN1 
screen, which was targeted specifically toward identifying new bi-
lobe proteins (Morriswood et al., 2013). This gave us confidence 
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control. During this time, the kinase is predominantly on the bilobe; 
we previously showed that inhibiting the kinase at this point blocks 
bilobe duplication. Bilobe-resident substrates should show dimin-
ished levels of phosphorylation if TbPLK is inhibited at this time 
(Lozano-Núñez et al., 2013).
We performed five SILAC and two iTRAQ experiments to iden-
tify novel TbPLK substrates. The SILAC experiments yielded 13 
proteins for which specific phosphosites were more than twofold 
down-regulated, whereas the iTRAQ experiments identified nine 
proteins with down-regulated phosphosites (Table 1 and Supple-
mental Figure S3). Overall, 20 regulated phosphosites were identi-
fied, nine of which were identified in both phosphoproteomic ap-
proaches (Figure 3A). Of the 13 possible substrates identified, four 
of the proteins are also present in the BioID screen, providing ad-
ditional evidence that they are TbPLK substrates (Figure 3B). Two of 
these proteins had been previously identified in other screens: 
Tb927.10.15750, termed p197, is a component of the tripartite at-
tachment complex that anchors the basal body to the kinetoplast, 
and Tb927.10.8820 is a bilobe component identified in the MORN1 
BioID screen (Gheiratmand et al., 2013; Morriswood et al., 2013).
Characterization of potential TbPLK binding partners 
and substrates
Identification of bilobe, basal body, and FAZ components among 
our candidates gave us confidence that many of the unidentified 
proteins would localize to the these compartments. However, most 
of the candidate proteins lacked conserved domains or homology 
to known proteins, and so it was difficult to choose a subset for fur-
ther study. Therefore we chose to endogenously tag each protein at 
its N-terminus with a triple-Ty1 epitope tag so that its localization 
could be established (Bastin et al., 1996; Morriswood et al., 2009). 
Endogenous tagging was essential to maintain cell cycle regulation 
of the candidate proteins and express the proteins at levels compa-
rable to their wild-type levels. Locus PCR and Ty1 Western blotting 
were used to confirm correct targeting of the triple-Ty1 tag. Once 
the cell lines were generated and confirmed, the localization of the 
Ty1 fusions was established by immunofluorescence, and the 
that our candidates included cytoskeletal proteins that are present 
on structures to which TbPLK localizes.
We also conducted additional experiments in which the initial 
cell lysis was performed with mild detergent, which extracts most 
of the cytoplasmic proteins but keeps the cytoskeleton intact 
(Morriswood et al., 2013). The resultant lysate was separated by 
centrifugation into a soluble fraction that contained mostly cytosolic 
proteins and a pellet fraction containing mostly cytoskeletal pro-
teins. Both fractions were incubated with streptavidin beads, and 
the bound proteins were identified. This fractionation step gave us 
information about the solubility of the bound proteins and improved 
LC-MS/MS detection by separating the biotinylated proteins into 
two samples, allowing us to identify new proteins that were not 
identified when the whole-cell lysate was analyzed. This approach 
yielded many of the same proteins seen in the whole-cell approach, 
but we found 11 new potential binding partners in the pellet frac-
tion and 8 in the soluble fraction (Table 1 and Supplemental Figure 
S2). The bilobe protein LRRP1, the FAZ protein CC2D, and the basal 
body protein KMP11 were also identified, showing that we were 
identifying components of structures to which TbPLK localizes dur-
ing the cell cycle (Zhou et al., 2010, 2011; Gheiratmand et al., 2013).
Identification of potential TbPLK substrates using 
phosphoproteomics
The divergent localization and function of TbPLK are likely reflected 
by novel substrates. Polo-like kinases do not have strong substrate 
recognition motifs (E/D/N-X-S/T), and the priming phosphorylation 
that targets the kinase to its substrates does not fall within a strongly 
conserved sequence (Lowery et al., 2007; Snead et al., 2007; Yun 
et al., 2009; Dou et al., 2011). To overcome these problems, we 
used two different quantitative phosphoproteomic methods to 
identify potential TbPLK substrates. Both methods take advantage 
of an analogue-sensitive TbPLK cell line that we generated recently 
(Lozano-Núñez et al., 2013). This method sensitizes kinases via a 
mutation in the ATP-binding site so that they can bind a modified 
general kinase inhibitor (Bishop et al., 2000; Burkard et al., 2007). 
The modification makes the inhibitor capable of inhibiting only ki-
nases with the mutation in their ATP-binding site. In wild-type cells, 
the modified inhibitor, known as 3MB-PP1, has no effect on growth, 
showing that the drug cannot inhibit any essential endogenous 
kinases. In cells in which the accommodating mutation has been 
installed within TbPLK, 3MB-PP1 treatment blocks cell division 
within 6 h of treatment. These results show that the TbPLKas cell line 
responds to drug treatment and that the drug has no effect on wild-
type cells, suggesting that any off-target effects of 3MB-PP1 are 
minimal (Lozano-Núñez et al., 2013).
We sought to identify in vivo TbPLK substrates by inhibiting Tb-
PLK in cells and monitoring changes in phosphorylation using quan-
titative MS methods. We used two distinct approaches that comple-
ment one another. First, we used a stable isotope labeling by amino 
acids in cell culture (SILAC) approach in asynchronous cultures, 
which requires labeling one sample with 13C/15N-labeled arginine 
and lysine and the other with unlabeled amino acids (Kean et al., 
2012; Urbaniak et al., 2012). One culture is treated with 5 μM 3MB-
PP1 to inhibit TbPLK and block phosphorylation, and the second 
sample is treated with a vehicle control. To improve our detection of 
changes in TbPLK phosphorylation at specific time points, we used 
a second proteomic approach (isobaric tags for relative and abso-
lute quantitation [iTRAQ]), which does not rely on metabolic label-
ing, coupled with a double-cut elutriation procedure to synchronize 
cells at the beginning of the cell cycle (Archer et al., 2011). After 
1.5 h in culture, the cells were treated with 3MB-PP1 or a vehicle 
FIGURE 3: Analysis of the BioID and phosphoproteomic screens. 
(A) Venn diagram showing overlap of the regulated phosphopeptides 
identified in the iTRAQ and SILAC screens. (B) Venn diagram showing 
overlap of the proteins identified in the BioID and phosphoproteomic 
screens.
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our Ty1 endogenous tagging cassettes 
for each protein into their cognate RNAi 
cell line so that we could directly monitor 
depletion of the proteins by Western blot-
ting (Chanez et al., 2006). We chose to 
focus on three candidates: Tb927.10.14320, 
Tb927.11.1340, and Tb927.11.15800. Our 
screen localization results suggested that 
the three proteins were cytoskeletal com-
ponents, and none of them had been char-
acterized previously.
A FAZ component plays an 
important role in the positioning 
of the kinetoplast
Tb927.10.14320 is a 121-kDa protein that 
was identified in our BioID screen. The pro-
tein contains an unstructured N-terminal 
domain and a C-terminal domain consisting 
of a series of armadillo repeats similar to 
those found in β-catenin (Peifer et al., 1994; 
Huber et al., 1997). These repeats can form 
extended binding surfaces and are found in 
proteins that form linkages with cytoskele-
tal elements. This protein was recently 
identified as a FAZ component in a pro-
teomic screen and was named FAZ9 (Sunter 
et al., 2015). Anti-Ty1 labeling showed that 
tagged FAZ9 localized to the FAZ through-
out the cell cycle (Figure 4A), confirming 
the localization of this protein. At the start 
of cell division, trypanosomes contain a 
single copy of the nucleus and kinetoplast 
(1N1K). Kinetoplast duplication occurs first 
(1N2K), followed by karyokinesis (2N2K). FAZ9 appears to be 
slightly more concentrated on the posterior end of the FAZ than 
along the rest of the structure.
FAZ9 depletion was complete within 72 h of induction of RNAi 
(Figure 4B). Cell counting showed no change in growth within 4 d of 
RNAi induction, although the depleted cells showed a small de-
crease in growth at later time points (Supplemental Figure S5). Dif-
ferential interference contrast (DIC) and 4′,6-diamidino-2-phenylin-
dole (DAPI) imaging at days 1–4 after RNAi induction showed no 
substantial changes in cell cycle distribution or DNA content (Supple-
mental Figure S6). However, it was apparent that in FAZ9-depleted 
cells, the kinetoplast was now located on the anterior side of the 
nucleus (Figure 5, A and B). This relocation normally occurs in PCFs 
during their migration from the fly midgut to the salivary glands while 
the parasite undergoes several morphological changes, including an 
asymmetric cell division that produces a small parasite with an ante-
riorly placed kinetoplast (Sharma et al., 2008; Rotureau et al., 2012). 
A recent report showed that depletion of another FAZ protein known 
as ClpGM6 causes trypomastigotes to become epimastigotes, along 
with an overall shortening of the cell body and the new FAZ (Hayes 
et al., 2014).
To test whether FAZ9 had any effect on the length of the new FAZ, 
we depleted the protein for 4 d and labeled cells with anti-FAZ1, 
which labels the filament, and 1B41, which labels the microtubule 
quartet (Gallo et al., 1988; Kohl et al., 1999; Vaughan et al., 2008). In 
FAZ9-depleted cells, the 1B41 signal became more disperse, label-
ing only the beginning and the end of the FAZ, along with the tip of 
the new FAZ in cells undergoing division (Figure 5C). Because of this 
pattern was compared with antibodies to markers of different cyto-
skeletal compartments (Supplemental Figure S4). We were able to 
select stable cell lines expressing detectable Ty1 fusions for all of 
our candidate proteins except for Tb927.3.4400, which required the 
relocation of the Ty1 tag to the C-terminus before viable cell lines 
could be established.
Our localization screen showed that many of our candidate pro-
teins were part of cytoskeletal compartments to which TbPLK is 
recruited during cell division (Figure 3C and Supplemental Figure 
S4). These include components of the bilobe (11), FAZ (nine), and 
basal body (eight). More unique identifications included a new fla-
gellar pocket collar protein (Tb927.11.5640), which has only a sin-
gle known protein component, BILBO1, and the first identified 
component of what appears to be the flagella connector 
(Tb927.11.1340; further evidence for this is provided later in this 
article). We also identified a small number of proteins (four) that 
look like they are associated with the plasma membrane or the 
subpellicular microtubules. Twenty-two of the proteins showed pri-
marily cytoplasmic labeling. When previously identified proteins 
are considered, our screen identified 40 cytoskeletal proteins lo-
calizing to a diverse set of compartments. The four candidates that 
were present in both our phosphoproteomic and BioID screens 
localized to the basal body (p197), FAZ (Tb927.11.15800), bilobe 
(Tb927.10.8820), and FPC (Tb927.11.5640).
As a follow-up to our localization screen, we chose a subset of 
the candidate proteins and performed more in-depth localization 
experiments and RNA interference (RNAi) using an inducible long 
hairpin RNAi (lhRNAi) strategy (Kalidas et al., 2011). We integrated 
FIGURE 4.: FAZ9 is a component of the FAZ. (A) Cells expressing 3X-Ty1-FAZ9 from the 
endogenous locus were fixed with methanol and labeled with an antibody against the FAZ (FAZ; 
red), anti-Ty1 (FAZ9; green), and DAPI to label the DNA (DNA; blue). The three rows show cells 
as they progress through the cell cycle. (B) FAZ9 RNAi cells expressing 3X-Ty1-FAZ9 from the 
endogenous locus were treated with doxycycline (DOX) or a vehicle control (Ctr). Cells were 
collected every 24 h to monitor FAZ9 depletion by Ty1 Western blotting, using tubulin as a 
loading control.
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although the Ty1 signal was very slightly off-
set from the AB1 signal, suggesting that the 
protein may localize to a different domain of 
the FC. We decided to call this protein FC1 
to reflect its localization. At early cell cycle 
stages, FC1 appears in the posterior of the 
cell in what is likely the flagellar pocket, 
where the connection between the two fla-
gella is established. Once the new flagellum 
has emerged onto the cell surface, the FC1 
puncta localizes to the contact point of the 
two flagella and remains there as the new 
flagellum extends along the old one. The 
FC1 signal disappears once the two flagella 
disconnect just before cytokinesis. Colabel-
ing with antibodies against TbPLK shows 
that the FC1 signal colocalizes with a por-
tion of the TbPLK signal early in the cell cy-
cle that is present at the tip of the new fla-
gellum (Figure 6B). We previously showed 
that this TbPLK labeling is present on the FC 
by immuno-electron microscopy on nega-
tively stained extracted cytoskeletons (Ikeda 
and de Graffenried, 2012). The TbPLK signal 
on the FC decreases later in the cell cycle, 
once the basal bodies begin to separate.
RNAi against FC1 showed efficient de-
pletion of the protein after 48 h by Western 
blotting of the Ty1-FC1 fusion, but no cell 
growth defect was observed even after 7 d 
of RNAi (Figure 7A and Supplemental 
Figure S7). The DNA state and general 
morphology of FC1-depleted cells were 
not disrupted (Supplemental Figure S8), al-
though we did observe disconnection of 
the tip of the new flagellum from the old 
flagellum (Figure 7B). This disconnection 
was evident at the 1N2K (48%) and 2N2K (59%) stages of cell divi-
sion (Figure 7C). Of importance, the new flagellum remained ad-
hered to the cell body. FC1 RNAi cells were induced with doxycy-
cline or vehicle control and then fixed and processed for scanning 
electron microscopy so that the state of flagella connection could 
be established at higher resolution at early and late stages of cell 
division. In vehicle control cells, the new flagellum was clearly in 
direct contact with the old flagellum both when the new flagellum 
had just emerged from the flagellar pocket and when it had ex-
tended along the cell surface, which would allow the transmission 
of positional information (Figure 7D). In FC1-depleted cells, it is 
difficult to tell whether the newly emerged flagellum is connected 
to the old flagellum, although the tip of the new flagellum appears 
to be free. In later stages of cell division, there was a clear gap of 
∼500 nm separating the two flagella, although the new flagellum 
appeared to be correctly positioned along the cell body with the 
same helical pattern seen in uninduced cells. This result argues that 
the biogenesis of the FC requires FC1 and that the FC may be 
dispensable for the correct positioning of the new flagellum during 
cell division.
A protein localizing to the tip of the extending FAZ 
is essential for cytokinesis
We next looked at the protein Tb927.11.15800, which contains 
two distinct domains—an N-terminal region that has similarities to 
phenotype, we chose to use the FAZ1 signal for further quantitation. 
Measurement of FAZ length in FAZ9-depleted cells at the 1N1K cell 
cycle stage showed that the structure maintained the same length as 
uninduced cells (control, 14.3 ± 1.6 μm; FAZ9 RNAi, 15.1 ± 1.7 μm). 
This differs substantially from ClpGM6 depletion, where newly as-
sembled FAZs are shorter but concentrate the same amount of fila-
ment components into the smaller structure, producing brighter FAZ 
labeling.
A component of the FC is essential for connection of the 
new and old flagella during cell division
We next focused on Tb927.11.1340, which contains an N-terminal 
kinase domain and a C-terminal domain of unknown function. This 
protein was identified as a putative TbPLK substrate in our SILAC 
phosphoproteomic screen, with two potential phosphosites (T888 
and S890) in the C-terminal domain that have been previously iden-
tified (Urbaniak et al., 2013). Ty1 tagging showed that the protein 
localizes to the connection point between the new and old flagella, 
which is the location of the flagella connector in PCFs. This cytoskel-
etal structure has no known components, although TbPLK does 
transiently localize to the FC during cell division (Ikeda and de 
Graffenried, 2012). To confirm the localization pattern, we stained 
the Ty1-tagged cells with AB1, a monoclonal antibody against an 
unknown protein that labels the FC (Figure 6A; Briggs et al., 2004). 
The Ty1-tagged protein labeled the FC throughout cell division, 
FIGURE 5: FAZ9 depletion causes relocation of the kinetoplast. (A) Cells that had been 
depleted of FAZ9 for 4 d were labeled with DAPI to label DNA and evaluated by fluorescence 
and DIC imaging. In the first column, the DNA channel is shown in monochrome, with the 
kinetoplasts marked by open arrowheads. In the second column, the DNA channel (DNA; blue) 
is merged with DIC in monochrome. The rows show cells as the progress in the cell cycle. 
(B) Quantitation of kinetoplast positioning in cells labeled as in A. (C) Control and FAZ9-
depleted cells were fixed and labeled with 1B41 (1B41; red), anti-FAZ1 (FAZ1; green), and DAPI 
to label the DNA. Cells were evaluated by fluorescence and DIC imaging. Arrowheads show the 
1B41 labeling, which is suppressed in FAZ9-depleted cells.
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cells in which TbPLK is concentrated on the 
anterior end of the bilobe structure, which is 
when the tip of the new FAZ becomes visi-
ble (Figure 8A). TbPLK and the protein colo-
calize at the tip of the new FAZ as the struc-
ture continues to extend, until the TbPLK 
signal begins to decline just before cytoki-
nesis (Figure 8B). We chose to name the 
protein TOEFAZ1 (Tip Of Extending FAZ) to 
reflect its localization pattern. Cleavage fur-
row ingression appears to occur from a 
point on the anterior side of the remaining 
TOEFAZ1 puncta late in the cell cycle.
Depletion of TOEFAZ1 is essentially 
complete after 24 h of RNAi induction 
(Figure 9A). Cell division was compromised 
within 2 d of initiation of RNAi, with the cells 
fully arresting growth by day 5 (Figure 9A). 
DIC and DAPI imaging after 1 d of RNAi 
showed a pronounced decrease in 1N1K 
cells and concomitant increase in 2N2K 
cells, with no change in 1N2K cells (Figure 
9B). In half of the TOEFAZ1-depleted 2N2K 
cells, the tip of the new flagellum had de-
tached from the old flagellum, which we 
rarely observed in uninduced samples 
(Figure 9, C and D). These changes were 
more pronounced 2 d after TOEFAZ1 deple-
tion, with 1N1K cells now comprising <10% 
of the population. The number of 1N2K cells 
decreased, whereas the number of 2N2K 
cells remained high. Multinucleated cells 
were the most common, comprising 37% of 
the population (Figure 9C). Cells lacking nu-
clei and cells containing additional kineto-
plasts were also evident at this time point. 
Attempts to quantitate DNA content at later 
time points were not feasible due to the in-
credibly high number of multinucleated cells 
with complex morphologies.
Considering the localization of TOEFAZ1 
during cell division and its apparent impor-
tance in cytokinesis, we stained TOEFAZ1-
depleted and control cells with antibodies 
against the FAZ and TbPLK. In uninduced 
cells, TbPLK localization followed its normal 
progression, starting on the basal body and 
bilobe in the posterior of 1N1K cells early in 
division, then progressing toward the ante-
rior end of the cell via the tip of the new FAZ 
and the FC during the late 1N1K and 1N2K 
states, until disappearing in 2N2K cells just 
before cytokinesis (Figure 10, A and B; Ikeda 
and de Graffenried, 2012). In TOEFAZ1-de-
pleted cells, TbPLK appeared at the basal 
body and bilobe in 1N1K cells that were just beginning to divide. 
However, TbPLK did not appear to localize to the tip of the new FAZ 
in late 1N1K cells, and the kinase was absent from the new FAZ tip 
in 1N2K and 2N2K cells as well (Figure 10, A and B). In contrast, 
TbPLK recruitment to the FC appeared to proceed normally. In a 
subset of 2N2K cells—frequently those with detached new flagel-
lum tips—TbPLK was associated with the duplicated basal bodies 
tricohyalins, which provide mechanical stability in epithelia, and a 
C-terminal domain that contains a zinc finger (Steinert et al., 1998, 
2003). This protein was identified in both our BioID and phospho-
proteomic screens and has four potentially regulated phosphosites 
(S15, S17, S18, and S33) in its N-terminal domain. The first three 
phosphosites were previously identified in another phosphopro-
teomic screen (Urbaniak et al., 2013). The protein first appears in 
FIGURE 6: FC1 is a component of the flagella connector. (A) Cells expressing 3X-Ty1-FC1 from 
the endogenous promoter were fixed and labeled with anti-Ty1 (FC1; green), an antibody 
against the FC (AB1; red), and DAPI (DNA; blue). The cells were visualized using fluorescence 
and DIC microscopy. The rows show different cells at progressively later points of the cell cycle. 
(B) The same cells as in A were fixed and labeled with anti-Ty1 (FC1; green), antibodies against 
TbPLK (TbPLK; red), and DAPI (DNA; blue). The rows show different cells at progressively later 
points of the cell cycle. Insets show threefold magnifications of the area surrounding the FC1 
signal.
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direct interactors, which could then be used 
to dissect the mechanism of kinase recruit-
ment. If TbPLK has evolved a novel mecha-
nism for localization, it would explain how its 
function has diverged so significantly from 
that of other PLK homologues (Park et al., 
2003; Bashor et al., 2008).
One unexpected result was the identifica-
tion of several nuclear pore components as 
potential TbPLK interactors. Although there 
is no evidence that full-length TbPLK enters 
the nucleus, it is possible that the kinase 
comes into the proximity of the nuclear pores 
as it is migrating throughout the cell, which 
might explain their presence as BioID hits. 
An alternative possibility is that these nuclear 
pore components are also part of the re-
cently identified ciliary pore complex, which 
functions as a selection filter for entrance into 
the cilia in mammalian cells (Kee et al., 2012; 
Obado and Rout, 2012). An analogous fla-
gellar pore complex has not yet been identi-
fied in trypanosomes, but if the structure is 
present, TbPLK may encounter the nuclear 
pore proteins as it migrates to the FC during 
production of the new flagellum.
FAZ9, which was identified in our BioID 
screen, appears to be involved in maintain-
ing cells in the trypomastigote form. In pro-
cyclic cells, the kinetoplast is initially found in 
the posterior of cells that occupy the fly mid-
gut. A highly asymmetric cell division that oc-
curs during the migration of the parasite to 
the proventriculus and esophagus produces 
a smaller cell in which the kinetoplast is pres-
ent on the anterior side of the nucleus (Sharma et al., 2008; Rotureau 
et al., 2012). This epimastigote form transitions to a slightly longer 
cell that is associated with the salivary gland epithelium and is able to 
divide. Depletion of the FAZ protein ClpGM6 produces smaller, epi-
mastigote-like cells (Hayes et al., 2014). Earlier work also showed that 
knockdown of the protein phosphatase PP1-3 causes kinetoplast re-
arrangement without affecting the length of the cell body; in this 
case, the nucleus is found closer to the posterior end of the cell, 
which leaves the kinetoplast closer to the anterior of the cell (Gallet 
et al., 2013). FAZ9 depletion causes a rearrangement more similar to 
PP1-3 because FAZ length remains the same as in control cells.
Our results show that kinetoplast positioning may rely on sev-
eral different FAZ components. One possibility for how this control 
is mediated is via the MtQ, which is the only FAZ component that 
interacts directly with the basal body (Lacomble et al., 2009). It is 
possible that changes in the FAZ filament affect the length or posi-
tioning of the MtQ, which could in turn change the positioning of 
the basal body and kinetoplast. FAZ9 depletion causes a decrease 
in FAZ labeling by the antibody 1B41, which is proposed to label 
an unknown modification of β-tubulin present exclusively on the 
MtQ. The consequence of this diminished labeling is unknown, al-
though it is likely that the MtQ remains intact. It is also possible 
that the FAZ plays a role in positioning the nucleus during cell 
division. The MtQ is associated with an extension of endoplasmic 
reticulum that is contiguous with the nuclear membrane (Taylor and 
Godfrey, 1969). This connection may facilitate nuclear separation 
during cell division and ensure that the nucleus is maintained in the 
and bilobes, which never occurred in cells containing TOEFAZ1. 
This phenotype is similar to what occurs upon inhibition of TbPLK, 
which causes the kinase to localize to the posterior of the cell in 
2N2K cells (Lozano-Núñez et al., 2013).
DISCUSSION
Of the 63 proteins identified in our proteomic screens, more than 
half localized to cytoskeletal compartments to which TbPLK local-
izes during cell division, such as the basal body, bilobe, and FAZ. 
Although these cytoskeletal components are strong candidates for 
involvement in TbPLK signaling pathways due to their localization, 
further work is necessary to confirm that they are direct substrates 
and/or binding partners of the kinase. Note that 11 of the 19 regu-
lated phosphosites fell within the PLK consensus sequence identi-
fied for the yeast and mammalian kinases, which indicates that they 
are more likely to be direct substrates if TbPLK has maintained the 
same specificity (Johnson et al., 2007; Snead et al., 2007; Murugan 
et al., 2011). All of the hits from our synchronized cell iTRAQ screen 
appeared among our SILAC hits, which provides additional evi-
dence that these proteins are components of TbPLK signaling path-
ways. It is unknown whether TbPLK binds to phosphorylated pro-
teins using the polo-box domain, as is the case with other PLK 
homologues, although most of our candidates contain the minimal 
serine-proline motifs that could function as substrates for upstream 
kinases to generate potential binding sites (Elia et al., 2003; Yun 
et al., 2009). Considering the lack of known TbPLK binding partners, 
the screen hits could be further studied biochemically to identify 
FIGURE 7: FC1 depletion causes a loss of connection between the new and old flagella. (A) FC1 
RNAi cells expressing 3X-Ty1-FC1 from the endogenous locus were treated with doxycycline 
(DOX) or a vehicle control (Ctr). Cells were collected every 24 h to monitor FC1 depletion by Ty1 
Western blotting, using tubulin as a loading control. (B) Uninduced and cells depleted of FC1 for 
2 d were treated with DAPI to label DNA (DNA; blue) and evaluated by fluorescence and DIC 
imaging. Images of 1N2K and 2N2K cells. Asterisks show detached new flagellar tips. 
(C) Quantitation of flagellar tip detachment of the data presented in B. (D) Selected scanning 
electron micrographs of control and FC1-depleted cells at both early and late stages of cell 
division. The arrows show the tips of the new flagella.
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microscopy and proposed to have a cytotac-
tic function that conveyed positional infor-
mation from the old flagellum to the new one 
(Moreira-Leite et al., 2001; Briggs et al., 
2004). However, no protein components of 
this structure had been previously identified, 
so its function could not be tested via 
methods such as RNAi. Depletion of FC1 
causes a loss of the connection between the 
two flagella tips but does not influence the 
positioning of the new flagellum or the viabil-
ity of procyclic trypanosomes. This strongly 
suggests that the FAZ may play a more 
prominent role in flagellar positioning than 
previously believed. The FC is present only in 
PCFs, whereas in BSFs, the tip of the new fla-
gellum is housed in a groove in the cell sur-
face that is adjacent to the MtQ and the FAZ 
filament (Hughes et al., 2013). This implies 
that the correct positioning of the new FAZ 
may be a more general mechanism for fla-
gellum placement across different life stages. 
Because positioning the new flagellum is es-
sential for the completion of cell division, it is 
likely that some redundancy is built into this 
process. FC1 and TbPLK are both kinases 
that may be components of a more extensive 
signaling network. One process that may be 
under their control is the movement of the 
FC, which stops once the structure has pro-
gressed to approximately half the length of 
the old flagellum (Davidge et al., 2006). Ac-
commodation of the further extension of the 
new flagellum appears to occur by separa-
tion of the basal bodies and elongation of 
the cell posterior. The timing and positioning 
of this event may require FC1 and TbPLK 
activity.
Our BioID and substrate screens identi-
fied TOEFAZ1, which localizes to the tip of 
the new FAZ as it extends during cell division 
in a manner similar to TbPLK. Depletion of 
TOEFAZ1 led to a block in cytokinesis, which 
argues that the tip of the new FAZ contains a 
complex that is essential for triggering furrow 
ingression. This inhibition of cytokinesis is 
very specific, because at early time points, 
we observe 2N2K cells that have detached 
new flagellar tips. This detachment is con-
fined to 2N2K cells, arguing that FC assem-
bly is not defective in TOEFAZ1-depleted 
cells. Disconnection of the new flagellum 
from the old one requires dissolution of the 
FC, which happens after furrow ingression 
has occurred. It is likely that the 2N2K cells 
are unable to initiate cytokinesis, but then proceed to flagellar discon-
nection, which appears to be independent of furrow ingression. The 
new FAZ tip structure may also contain an Aurora kinase homologue 
and the chromosomal passenger complex proteins CPC1 and CPC2, 
which form a complex (Li et al., 2008a,b). These proteins are associ-
ated with formation of the mitotic spindle but then exit the nucleus 
and migrate to a location that is consistent with the tip of the new 
correct location. Disruption of this connection could lead to repo-
sitioning of the nucleus to a more posterior location, which would 
produce epimastigotes. We are investigating which of these mod-
els best describes the consequence of FAZ9 depletion.
We have identified FC1 as the first component, to our knowledge, 
of the flagella connector in our TbPLK phosphoproteomic screen. 
This structure was initially identified morphologically by electron 
FIGURE 8: TOEFAZ1 localizes to the tip of the new FAZ. (A) Cells expressing 3X-Ty1-TOEFAZ1 
from the endogenous promoter were fixed and labeled with an antibody against the FAZ (FAZ; 
red), anti-Ty1 (TOEFAZ1; green), and DAPI to label the DNA (DNA; blue). The cells were then 
imaged by fluorescence and DIC microscopy. The rows show different cells at progressively later 
points of the cell cycle. (B) The same cell line as in A was fixed and labeled with antibodies 
against TbPLK (TbPLK; red), anti-Ty1 (TOEFAZ1; green), and DAPI to label the DNA (DNA; blue). 
The rows show different cells at progressively later points of the cell cycle. Empty arrowheads 
show the TbPLK labeling on the flagella connector, and filled arrowheads show the TOEFAZ1 
present late in the cell cycle at the point of cleavage furrow ingression.
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work is necessary to establish the precise timing of the phosphoryla-
tion events, which might suggest other functions.
In this work, we have used a series of proteomic methods to 
identify candidate binding partners and substrates for TbPLK. This 
process is vital for moving from a descriptive understanding of 
TbPLK function, based strictly on observation of kinase migration 
and the consequences of kinase inhibition, to a more mechanistic 
understanding developed from establishing signaling circuits com-
prising kinase binding partners and substrates. Because TbPLK is 
involved in many essential processes throughout cell division, 
these circuits will be important for events such as FAZ and bilobe 
duplication, basal body rotation, and cytokinesis. A better under-
standing of the unique aspects of T. brucei cell division will un-
cover novel pathways for drug discovery, which is a vital concern.
MATERIALS AND METHODS
Cell culture
Experiments were performed in wild-type procyclic T. brucei brucei 
427 strain and 427 cells carrying the machinery necessary for 
doxycycline inducibility (29-13). The 427 cells were cultured at 27°C 
in SDM-79 medium supplemented with 7.5 μg/ml hemin and 20% 
FAZ. They are present at the location of the furrow and may also par-
ticipate in positioning this structure. However, it should be noted that 
depletion of these proteins does not lead to an accumulation of 2N2K 
cells, as is the case with TOEFAZ1, although this may be due to their 
involvement in spindle pole formation. It is possible that the Aurora/
CPC complex is recruited to the tip of the new FAZ to mark the com-
pletion of karyokinesis and signal that cytokinesis can proceed.
TOEFAZ1 depletion changes the distribution of TbPLK during 
the later stages of cell division. The kinase usually localizes to both 
the new FAZ tip and the FC as the new FAZ and flagellum are ex-
tending, but depleting TOEFAZ1 specifically blocks the recruitment 
of TbPLK to the new FAZ. This loss of localization is remarkably 
specific and has no effect on the FC-localized TbPLK. This suggests 
that TbPLK requires TOEFAZ1 to be recruited to the new FAZ, per-
haps as a direct binding partner. TOEFAZ1 is a highly phosphory-
lated protein, and several of these sites fall within potential PLK-
binding sites (Elia et al., 2003; Snead et al., 2007). The regulated 
TbPLK phosphosites are found in the TOEFAZ1 N-terminus, which is 
predicted to be a helical domain but lacks homology to any known 
structure. The function of these phosphosites may be important for 
loading TOEFAZ1 onto the tip of the new FAZ, although further 
FIGURE 9: TOEFAZ1 depletion causes defects in cytokinesis. (A) TOEFAZ1 RNAi cells expressing 3X-Ty1-TOEFAZ1 
from the endogenous locus were treated with doxycycline (DOX) or a vehicle control (Ctr). Cells were collected every 
24 h to monitor TOEFAZ1 depletion by Ty1 Western blotting, using tubulin as a loading control. TOEFAZ1 RNAi cells 
were treated with doxycycline (TOEFAZ1 RNAi) or a vehicle control (Control), and the cell number was monitored over 
6 d. (B) Quantitation of the DNA states of TOEFAZ1-depleted cells (TOEFAZ1 RNAi) and control cells (Control) after 1 d 
(gray, light red) or 2 d (black, red) of induction. 3K+XN, cells with three kinetoplasts and either one or two nuclei. 
2K+0N, cells with two kinetoplasts and no nuclei. (C) Uninduced (Control) and cells depleted of TOEFAZ1 for 1 d 
(TOEFAZ1 RNAi) were treated with DAPI to label DNA (DNA; blue) and evaluated by fluorescence and DIC imaging. 
Asterisk shows detached new flagellum tip. (D) Quantitation of new flagellum tip detachment in cells depleted of 
TOEFAZ1 (TOEFAZ1 RNAi and Control cells).
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The myc-BirA*-TbPLK construct was assembled in the vector 
pLEW100 by cloning myc-BirA* into a pLEW100 variant that already 
contained the TbPLK open reading frame using the restriction en-
zymes HindIII and BamHI, which installed the biotinylation machin-
ery at the N-terminus of the kinase. Myc-BirA* was previously used 
in T. brucei (Morriswood et al., 2013). The completed plasmid was 
linearized with NotI, and clonal lines were selected with 5 μg/ml 
phleomycin.
Endogenous tagging with a triple-Ty1 tag was accomplished using 
previously described methods (Morriswood et al., 2009). Targeting 
the tag to the N-terminus of the endogenous locus of each candidate 
protein was mediated by 500 base pairs of 5′ untranslated region se-
quence and the first 500 base pairs of the open reading frame. The 
targeting constructs were assembled in a sequencing plasmid 
(PCR4Blunt) and then excised by restriction digest before electropor-
ation into 427 cells. Clonal lines were selected with 20 μg/ml blastici-
din. Presumed clones were screened for correct recombination at the 
endogenous locus by PCR using genomic DNA, followed by Ty1 
Western blotting and immunofluorescence microscopy.
Doxycycline-inducible RNAi stem-loops were assembled in 
pTrypRNAiGate using previously published methods (Kalidas 
et al., 2011). Targeting sequences were chosen using the RNAit 
software (trypanofan.bioc.cam.ac.uk/software/RNAit.html). The 
specific gene segments are as follows: TOEFAZ1, nucleotides 
(nt) 578–1090; FC1, nt 1265–1763; and FAZ9, nt 1511–1687. The 
completed RNAi constructs were then linearized using the 
fetal calf serum (Sigma-Aldrich, St. Louis, MO). The 29-13 cells were 
cultured at 27°C in SDM-79 medium supplemented with 7.5 μg/ml 
hemin, 20% doxycycline-free fetal calf serum (Clontech, Mountain 
View, CA), 50 μg/ml hygromycin, and 15 μg/ml neomycin. Cell 
growth was monitored using a particle counter (Z2 Coulter Counter, 
Beckman Coulter, Brea, CA; Moxi Z, Orflo, Ketchum, ID).
Antibodies
Antibodies were obtained from the following sources: anti-FAZ1 
and AB1 from Keith Gull (Oxford University, Oxford, United King-
dom), anti–Leishmania donovani Centrin4 from Hira L. Nakhasi (U.S. 
Food and Drug Administration, Washington, DC), anti-Ty1 from 
Cynthia He (National University of Singapore, Singapore), 1B41 
(Linda Kohl, Centre National de la Recherche Scientifique, Paris, 
France), anti-BILBO1 (Gang Dong, Max F. Perutz Laboratories, Vi-
enna, Austria), 20H5 (Millipore Biosciences), and anti-TBBC (Etienne 
Pays, Université Libre de Bruxelles, Brussels, Belgium). The mono-
clonal antibodies against TbCentrin2 and TbCentrin4 and antibod-
ies against TbPLK have been described previously (de Graffenried 
et al., 2008; Ikeda and de Graffenried, 2012).
Cloning and cell line assembly
All DNA constructs were validated by sequencing. Verified con-
structs were introduced into cells using electroporation with a 
GenePulser Xcell (Bio-Rad, Hercules, CA), and clonal cell lines were 
generated by selection and limiting dilution.
FIGURE 10: TOEFAZ1 depletion blocks recruitment of TbPLK to the tip of the new FAZ. (A) Control cells (Control) and 
cells depleted of TOEFAZ1 for 1 d (TOEFAZ1 RNAi) were fixed and labeled with an antibody against the FAZ (FAZ; red), 
antibodies against TbPLK (TbPLK; green), and DAPI to label the DNA (DNA; blue). Both samples were imaged using 
fluorescence and DIC microscopy. Filled arrowheads show the TbPLK labeling within the cell body, asterisks show 
TbPLK at the FC, and empty arrowheads show TbPLK that has been loaded onto the basal body region in 2N2K cells, 
which is aberrant. Rows show cells progressing through the cell cycle. (B) Quantitation of the localization of TbPLK in the 
control cells (Control) and TOEFAZ1-depleted (TOEFAZ1 RNAi) cells in A, sorted by DNA state.
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and then rehydrated in PBS. For extracted cytoskeletons, the cells 
on coverslips were incubated in extraction buffer (0.1 M PIPES, 
pH 6.9, 2 mM EGTA, 1 mM MgSO4, 0.1 mM EDTA, 1% NP-40) for 
5 min at room temperature, washed in PBS three times, followed 
by fixation in −20°C methanol for 20 min and rehydration in PBS. 
The cells were blocked overnight at 4°C in blocking buffer (PBS 
containing 3% bovine serum albumin). Primary antibodies were di-
luted in blocking buffer and incubated for 1 h at room temperature 
and then washed four times in PBS and placed in blocking buffer 
for 20 min. Alexa 488– or 568–conjugated secondary antibodies 
(Life Technologies, Carlsbad, CA) were diluted in blocking buffer 
and incubated for 1 h at room temperature. Cells were washed and 
mounted in Fluoromount G with DAPI (Southern Biotech, Birming-
ham, AL). Coverslips were imaged using a Zeiss Observer Z1 
equipped with a CoolSNAP HQ2 camera (Photometrics, Tucson, 
AZ) and a Plan-Apochromat 63×/1.4 oil immersion lens (Zeiss, 
Thornwood, NY). AxioVision, release 4.8, was used to control the 
microscope for acquisition. All images were quantified in ImageJ 
(National Institutes of Health, Bethesda, MD) and assembled for 
publication using Photoshop CS5 and Illustrator CS5.
Western/streptavidin blotting
Cells were harvested, washed once in PBS, and then lysed in SDS–
PAGE loading buffer. A total of 3 × 106 cell equivalents of lysate/lane 
was fractionated using SDS–PAGE, transferred to nitrocellulose, and 
blocked for 1 h at room temperature. For antibody detection, block-
ing and antibody dilution were done in Tris-buffered saline (TBS) 
supplemented with 5% nonfat milk and 0.1% Tween-20. Primary 
antibodies were incubated overnight at 4°C, followed by washing 
in TBS containing 0.1% Tween-20 and incubation with secondary 
antibodies conjugated to horseradish peroxidase (HRP; Jackson 
Immuno Research, West Grove, PA). For streptavidin blotting, mem-
branes were blocked in 10% milk and 0.3% Tween-20 in PBS and 
then incubated with HRP-conjugated streptavidin (Life Technolo-
gies) overnight at 4°C. The blots were then washed in PBS/0.3% 
Tween-20. Clarity (Bio-Rad) ECL substrate and a Bio-Rad Gel Doc 
XR+ documentation system were used for detection.
Measurements
FAZ length measurements were conducted using the freehand 
drawing tool in ImageJ (1.49J). Before measurement, black and 
white maximum intensity Z-projections of the FAZ channel were 
generated to ensure that the full length of the structure was evident. 
The DNA channel was used to select 1N1K cells. The measurements 
were exported to Excel for analysis.
Statistics
All error bars represent the SD from the mean for three biological 
replicates. For DNA counting and phenotype quantitation by mi-
croscopy, at least 250 cells were counted for the RNAi and control 
conditions for each biological replicate. For FAZ measurements, 
100 FAZs from 1N1K cells for the RNAi and control conditions were 
selected for each biological replicate.
SILAC experiments
For the SILAC experiments, cells were grown in SDM-79 lacking ar-
ginine and lysine (Caisson Labs, North Logan, UT) supplemented 
with 20% dialyzed serum (Invitrogen). The medium was further sup-
plemented with either isotopically labeled 126 μg/ml arginine (13C6, 
99%; 15N4, 99%; Cambridge Isotope Laboratories, Tewksbury, MA) 
and 75 μg/ml lysine (13C6, 99%; Cambridge Isotope Laboratories) 
or unlabeled amino acids. Cells with and without the isotopically 
restriction enzyme NotI and electroporated into the 29-13 cell 
line (Wirtz et al., 1999). Stable transformants were selected with 
20 μg/ml Zeocin (Invitrogen, Carlsbad, CA), and clonal cell lines 
were generated by limiting dilution. Endogenous replacement of 
TOEFAZ1, FC1, and FAZ9 in the 29-13 cell lines carrying the 
complementary RNAi construct with the Ty1 epitope at the 
N-terminus was accomplished as described.
RNAi
Cultures of TOEFAZ1, FC1, or FAZ9 RNAi cells were seeded at 
1 × 106 cells/ml and induced by adding 1 μg/ml doxycycline, and 
70% ethanol was added to control cells. Cells were maintained at 
27°C and reseeded every 48 h with fresh medium and doxycycline. 
Cells were counted every 24 h and samples taken for Western blot 
analysis and immunofluorescence microscopy. All cell counts are the 
average of three biological replicates, and the error bars are the SE. 
For quantitation by microscopy, FC1 was depleted for 2 d, TOEFAZ1 
for 1 d, and FAZ9 for 4 d, unless otherwise noted.
Scanning electron microscopy
EM-grade glutaraldehyde (TAAB, Reading, United Kingdom) was 
added directly to the suspension culture flask directly from the incu-
bator to a final concentration of 2.5% EM-grade glutaraldehyde. 
The fixed cell suspension was then resuspended in primary fixative 
of 2.5% EM-grade glutaraldehyde in phosphate-buffered saline 
(PBS) for 2 h at room temperature on a rocking stage. Cells were 
washed twice with PBS and settled onto 13-mm round glass cover-
slips. Once adhered, the coverslips were washed with double-dis-
tilled dH2O to remove any buffer. Dehydration steps were 30, 50, 
70, and 90% ethanol in H2O added sequentially to the coverslips for 
5 min each, followed by 3 × 5 min in 100% ethanol. Finally, the 
samples were dried using a critical point dryer and coated with gold 
using a sputter coater. Images were taken on a Hitachi S-3400N.
BioID
The myc-BirA*-TbPLK cell line was seeded in medium supple-
mented with 50 μM biotin for 24 h before induction. Two 500-ml 
cultures were seeded at 4 × 106 cells/ml and then induced for 18 h 
with either 20 ng/ml doxycycline to initiate expression of myc-
BirA*-TbPLK or a vehicle control (70% ethanol). The cells were har-
vested by centrifugation, and biotinylated proteins were isolated 
on streptavidin beads as described previously (Roux et al., 2012; 
Morriswood et al., 2013). For the BioID conducted on soluble and 
pellet fractions, the harvested cell pellets were resuspended in 
PEME buffer (2 mM ethylene glycol tetraacetic acid [EGTA], 1 mM 
MgSO4, 0.1 mM EDTA, 0.1 M 1,4-piperazinediethanesulfonic acid 
[PIPES], pH 6.9) supplemented with 0.5% NP-40 and a cOmplete 
(Roche) protease inhibitor pellet for 5 min at room temperature. 
The samples were then centrifuged at 14,000 × g for 10 min at 
room temperature. The supernatant fraction was separated from 
the pellet, and biotinylated proteins were isolated as described. 
The pellet fractions were washed once with PEME plus 0.25% NP-
40 and then resuspended in BioID lysis buffer (0.4% SDS, 2% Triton 
X-100, 500 mM NaCl, 5 mM EDTA, 1 mM dithiothreitol [DTT], 
50 mM Tris, pH 7.4) followed by isolation of biotinylated proteins.
Immunofluorescence
Cells were harvested, washed once in PBS, and then adhered to 
coverslips. For DNA and DIC analysis, cells were fixed in 4% para-
formaldehyde in PBS for 20 min at room temperature, followed by 
three washes in PBS before mounting. For direct methanol fixation, 
the cells were immersed in –20°C methanol for 20 min, air dried, 
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Peptide identifications were accepted if a probability >95% was as-
signed by the Protein Prophet algorithm. Protein identifications were 
accepted if they could be established at a probability >99%. A list of 
potential specific TbPLK interaction partners was generated taking 
into account the spectral counts in the induced and noninduced 
samples and the occurrence in biological replicates.
All mass spectrometers used, including electrospray ionization 
source, and HPLC systems, including columns, were from Thermo 
Fisher Scientific/Dionex if not otherwise specified.
Trypsinization and peptide isolation for phosphoproteomics
Crude cell extracts were digested to peptides in a filtration device, 
a method termed filter-aided sample preparation (FASP). For the 
iTRAQ samples, the FASP protocol was used essentially as de-
scribed (Wis´niewski et al., 2009). Cell lysates were sonicated for 
5 min and then mixed with 3 ml UA (8 M urea, 50 mM triethylam-
monium bicarbonate [TEAB], pH 8). This solution was loaded onto 
an Amicon Ultra-4 centrifugal filter unit with a 30-kDa MWCO (UFC 
903024; Millipore, Billerica, MA). Filter units were centrifuged at 
4000 × g at room temperature until the retentate was reduced to 
1/10 of the starting volume. The retenate was washed two times 
with UA with subsequent centrifuging. For reduction of the disulfide 
bridges, the sample was incubated with 1 μg of Tris(2-carboxyehtyl) 
phosphine/2.5 μg of protein for 1 h at 60°C. Then the thiol groups 
were alkylated by adding 17 μl of 200 mM methyl methanesulfono-
thioate (MMTS; 1 μg/2.5 μg of protein) and incubating for 30 min in 
the dark. The filter units were then washed twice with UA and then 
twice with 3 ml of 0.8 M urea and 50 mM TEAB, pH 8. Proteins were 
digested with trypsin (1 μg/30–50 μg of protein) at 37°C overnight 
with gentle shaking. Liquid that passed through the filter was com-
bined with the retenate, and trypsin at a ratio of 1 μg of tryp-
sin/200 μg of protein was added and incubated for another 2–4 h 
for completing the digest. Filter tubes were centrifuged (4000 × g 
at room temperature) until void volume was reached and then 
washed twice with 200 μl of 50 mM TEAB, pH 8 (5-min incubation). 
The filtrates were pooled and lyophilized to dryness.
The SILAC samples were processed with the following excep-
tions: sonicated cell extracts were loaded onto an Amicon Ultra-15 
centrifugal filter. Protocol was performed with 10 ml of 8 M urea and 
50 mM ammonium bicarbonate (ABC) instead of UA. Washing steps 
were preceded by 10 ml of 8 M urea plus 50 mM ABC and 0.8 M 
urea plus 50 mM ABC, respectively. Disulfide groups were reduced 
with DTT (1 μg of DTT/20 μg of protein) for 30 min at 56°C and 
subsequently alkylated with iodoacetamide (IAA; 1 μg of IAA/4 μg 
of protein) for 20 min in the dark.
iTRAQ labeling
Peptides were labeled with iTRAQ (ABSciex, Redwood City, CA) 
according to the manufacturer’s instructions. Each dried sample 
was dissolved in 100 μl of 500 mM TEAB, pH 8, and labeled for 
2.5 h at room temperature with 1 U of labeling reagent diluted in 
70 μl of ethanol/250 μg of peptide. Labeling efficiency was tested 
in an LC-MS/MS run at the PSM level and found to be >98% for all 
labels. For confident quantification ratios, we performed duplicate 
duplex experiments: each sample was split, and each half was la-
beled with a different iTRAQ reagent (either labels 114 and 115 or 
labels 116 and 117 were combined). The four channels were mixed 
at a 1:1:1:1 ratio (mixing deviation was defined in an LC-MS run 
and found to be <10%) and desalted with Strata-X SPE cartridges 
(Phenomenex, Torrance, CA) and lyophilized.
Desalting was performed with Strata-X SPE cartridges 
(Phenomenex) conditioned with 70% ACN, 0.1% formic acid [FA], 
labeled amino acids were grown for six cell cycles to allow for full 
incorporation, which was confirmed by LC-MS/MS of the labeled 
sample. Growth of both cultures was monitored to ensure that 
there was no difference in cell proliferation. Cultures containing 
3.1 × 108 cells each were seeded at 2.5 × 106 cells/ml. The light 
sample was treated with 5 μM 3MB-PP1 for 2 h, and the heavy 
sample was treated with DMSO as a vehicle control. The samples 
were incubated at 27°C for 2 h, at which point the cells were pel-
leted, combined, and washed once with serum-free SDM-79 lack-
ing Arg and Lys. The combined pellet was then lysed in modified 
RIPA buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 2 mM EDTA, 
1% NP-40, 0.1% SDS) containing 3 M urea and one tablet each 
of phosSTOP phosphatase inhibitors (Roche, Branford, CT) and 
cOmplete mini protease inhibitors per 5 ml of lysis buffer. The 
sample was centrifuged at 10,000 × g at 4°C for 10 min, and then 
the supernatant was processed for phosphoproteomic analysis.
Double-cut elutriation/iTRAQ
Double-cut elutriation on TbPLK analogue–sensitive cells was per-
formed as previously described (Lozano-Núñez et al., 2013). Briefly, 
∼4 × 109 cells were collected for double-cut elutriation, which was 
performed as previously described (Archer et al., 2011), except for 
the interval between the first and second cuts, which was extended 
to 90 min. Equal quantities of synchronous cells were split into two 
cultures and allowed to progress through the cell cycle for 90 min, 
when 5 μM 3MB-PP1 was added to one culture and a vehicle control 
(DMSO) was added to the other. The two cultures were incubated at 
27°C for 1 h, then washed and lysed in modified RIPA buffer as per-
formed in the SILAC experiments.
BioID sample processing and LC-MS/MS
Samples were processed and analyzed essentially as previously de-
scribed (Morriswood et al., 2013). Beads were washed with 50 mM 
ammonium bicarbonate, disulfide bridges were reduced with DTT, 
and thiols were alkylated with iodoacetamide. Proteins were di-
gested on bead with trypsin (recombinant, proteomics grade; 
Roche) overnight at 37°C. Acidified peptides were separated on an 
UltiMate 3000 nanoHPLC or an UltiMate 3000 nanoRSLC applying a 
90-min linear gradient from 2 to 32% acetonitrile (ACN) on a C18 
analytical column.
The high-performance liquid chromatograph (HPLC) was directly 
coupled to an LTQ-Orbitrap Velos mass spectrometer via a nano 
electrospray ionization source. The electrospray voltage was set to 
1.5 kV. The mass spectrometer was operated in the data-dependent 
mode: one full scan (m/z = 350–1800, resolution 60,000) was fol-
lowed by maximal 20 MS/MS scans. The lock mass was enabled and 
set at the signal of polydimethylcyclosiloxane at m/z = 445.120025. 
Monoisotopic precursor selection was enabled, and singly charged 
signals were excluded from fragmentation. The collision energy was 
set at 35%, Q-value at 0.25, and activation time at 10 ms.
Data interpretation
Raw spectra were interpreted by Mascot 2.2.04 (Matrix Science, 
Boston, MA) using Mascot Daemon 2.2.2. Spectra were searched 
against the TriTryp database of Tbrucei427 and Tbrucei927 (18,355 
entries, 23-apr-2012, tritrypdb.org/), including common contami-
nants. The following search parameters were used: peptide tolerance 
was set to 2 ppm, MS/MS tolerance to 0.8 Da, trypsin was selected 
as protease and two missed cleavages were allowed, and carbamido-
methyl cysteine was set as static modification and oxidation of me-
thionine as a variable modification. MASCOT results were loaded 
into Scaffold (version 3.00.02; Proteome Software, Portland, OR). 
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iTRAQ data analysis
Raw files were processed with the Proteome Discoverer 1.4.0.288 
(Thermo Fisher Scientific, Waltham, MA). Spectra were searched 
with the following parameters with Mascot (Matrix Science): proteo-
lytic specificity of trypsin allowing two missed cleavages, MMTS al-
kylation of cysteines as fixed modification, oxidation of Met, phos-
phorylation of Ser, Thr, and Tyr, and labeling of the N-terminus of 
peptides and of Lys and Tyr with iTRAQ as variable modification. 
Precursor tolerance was set to 10 ppm and fragment tolerance for 
CID spectra to 0.8 Da and for HCD spectra to 20 mDa.
Quantitative data in the HCD scans were interpreted with the 
reporter ion quantitation node in the Proteome Discoverer with an 
integration tolerance of 20 mDa. Results were filtered for com-
plete iTRAQ labeling of the peptides. Unbalanced mixing of the 
four channels was corrected based on the ratio of the duplicated 
channels; quantification data with one channel missing were not 
considered. The phosphorylated peptides exhibiting an inhibitor 
dependence (ratio >2 or <0.5) were manually inspected regarding 
identity and quantitation.
SILAC SCX separation
Phosphopeptides were further fractionated on an UltiMate Plus 
nano HPLC equipped with a SCX column from PolyLC 
(PolySULFOETHYL A, 100 × 2.1 mm, 3 μm, 100 Å). The lyophilized 
samples were dissolved in 60 μl of 5 mM Na-PO4, pH 2.7, buffer 
with 15% ACN and loaded on the SCX column. A 60-min linear 
gradient was applied from 0 to 500 mM NaCl in 5 mM NaPO4, 
pH 2.7, buffer with 15% ACN at a flow rate of 30 μl/min. One-minute 
fractions were collected over 100 min and pooled depending on 
their peptide content before the LC-MS measurement.
SILAC LC-MS/MS
The desalted SCX-fractions from the SILAC experiments were sepa-
rated on an UltiMate 3000 nanoRSLC essentially as described for the 
iTRAQ samples. After the samples were preconcentrated on a C18 
reversed-phase trap column, the peptides were separated on a C18 
reversed-phase analytical column, applying a 60-min linear gradient 
from 1.6 to 32% ACN with 0.08% FA at a flow rate of 275 nl/min. The 
HPLC was coupled to an LTQ Orbitrap Velos mass spectrometer via 
a nano-electrospray ionization source. The mass spectrometer was 
operated in a data-dependent mode: one full scan in the Orbitrap 
(m/z = 350–2000, 60,000 resolution) was followed by MSMS scans in 
the linear ion trap of the 12 most intense precursor ions (35% colli-
sion energy; Q-value 0.25; activation time 10 ms). Internal calibra-
tion with lock mass (m/z = 445.120024, polydimethylcyclosiloxane) 
was enabled. Precursors with charge state 1 were excluded for frag-
mentation. Monoisotopic precursor selection was enabled. Frag-
mented ions were put on an exclusion list for 30 s.
The first SILAC experiment was measured on a QExactive: one 
full scan in the Orbitrap (m/z = 350–2000, 70,000 resolution) was 
followed by HCD fragmentation of the 10 most intense precursor 
ions (30% normalized collision energy). During manual validation, 
we observed jagged peaks in the extracted ion chromatograms, 
which led to false quantitation ratios especially when signals were 
low. Therefore the following SILAC experiments were all measured 
on an LTQ Orbitrap Velos.
SILAC data analysis
SILAC data were interpreted with MaxQuant 1.5.0. Raw data were 
searched against the TriTryp database with tryptic specificity allow-
ing a maximum of two missed cleavages. Oxidation of methionine 
and phosphorylation of serine, threonine, and tyrosine were set as 
followed by equilibration with 0.1% trifluoroacetic acid [TFA]. After 
sample loading, washing was performed with 0.1% TFA, followed 
by 0.1% FA, and then elution with 70% ACN, 0.1% FA). In some 
cases SEP-PAK tC18 cartridges (Waters) or Empore C18 SD (3M) 
were employed. These cartridges were washed with 100% MeOH, 
conditioned with 70% ACN and 0.1% FA, and then equilibrated 
with 0.1% TFA. After sample loading, they were washed with 0.1% 
TFA, followed by 0.1% FA, and then eluted with 70% ACN and 
0.1% FA. Eluates were lyophilized.
Phosphopeptide enrichment
Phosphopeptide enrichment was essentially performed as de-
scribed previously (Bodenmiller et al., 2007). Peptides of 1.7 mg of 
digested protein were reconstituted in 280 μl of solution of 80% 
ACN and 3.5% TFA saturated with phthalic acid. The peptides were 
added to 850 μg of TiO2 spheres (GL Sciences, Tokyo, Japan) equil-
ibrated with the saturated phthalic acid solution and incubated in a 
Mobicol spin column (MoBiTec, Goettingen, Germany) for 30 min 
while rotating. The column was washed two times with 200 μl of 
saturated phthalic acid solution, two times with 300 μl of 80% ACN 
and 0.1% TFA, and finally two times with 300 μl of 1%ACN and 
0.1% TFA. The bound peptides were eluted with two times with 
150 μl of 0.3 M NH4OH solution. The eluates were combined and 
acidified immediately with 5 μl of concentrated TFA.
iTRAQ strong cation exchange
Fractionation of phosphopeptides by strong cation exchange (SCX) 
tips (Glygen; Top Tip PolySULFOETHYL A; Columbia, MD) was per-
formed following an adapted protocol: washing with 2 × 30 μl of 
30% ACN, 2 × 30 μl of 80% ACN, 2 × 30 μl of H2O; conditioning with 
30 μl of 5 mM NaPO4, pH 2.7, 15% ACN, and 500 mM NaCl. Tips 
were equilibrated with 10 times 30 μl of 5 mM NaPO4, pH 2.7, and 
15% ACN. Desalted and freeze-dried peptide samples were dis-
solved in 30 μl of 5 mM NaPO4, pH 2.7, and 15%ACN, loaded 
slowly onto the tips, and washed with 20 μl of 5 mM Na-PO4, 
pH 2.7, and 15% ACN. Bound peptides were eluted by a six-step 
elution with increasing salt concentration (20, 30, 40, 60, 100, 
300 mM NaCl; 30-μl fraction volume). Fractions were reduced to a 
volume of 5 μl in a SpeedVac in order to evaporate ACN and then 
filled up to a final volume of 50 μl with 0.1% TFA.
iTRAQ LC-MS/MS
Peptides were separated on a U3000 nano RSLC system. Each frac-
tion was loaded on a trapping column (PepMap C18, 5-μm particle 
size, 300-μm inner diameter × 5 mm) equilibrated with 0.1% TFA and 
separated on an analytical column (PepMap C18, 3 μm, 75-μm inner 
diameter × 150 mm) by applying a 180-min linear gradient from 1.6 
to 32% ACN with 0.1% formic acid followed by a washing step with 
80% ACN. The nano-HPLC was directly coupled to the LTQ-Orbitrap 
Velos hybrid mass spectrometer via the electrospray ionization 
source. The mass spectrometer was operated in the data-dependent 
mode: one full scan (m/z = 350–2000, resolution 60,000) was fol-
lowed by alternate fragmentation of the top five precursors with 
higher-energy collisional dissociation (HCD) and collision-induced 
dissociation (CID). For internal calibration, the lock mass was set at 
the signal of polydimethylcyclosiloxane at m/z = 445.120025. Mo-
noisotopic precursor selection was enabled; precursors with charge 
state 1 were excluded from fragmentation. The collision energy for 
CID was set at 35%, Q-value at 0.25, and activation time at 10 ms. 
For HCD, the collision energy was set at 45% and activation time at 
0.1 ms. Fragmented ions were excluded from further fragmentation 
for 60 s.
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